SLC2A1 and neoplasm: This study suggests that NBP interaction with HER3 activates a singular route for ligand-directed nanocarrier transfer across the BBB and into IC tumours, and offers advantages over using conventional BBB transporters, TfR and GLUT1, for targeting brain metastases.